Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system

• Published in: Canadian journal of physiology and pharmacology Vol. 85; no. 9; p. 933
• Main Authors: Awad, R, Levac, D, Cybulska, P, Merali, Z, Trudeau, V L, Arnason, J T
• Format: Journal Article
• Language: English
• Published: Canada 01-09-2007
• Subjects: 4-Aminobutyrate Transaminase - metabolism; Animals; Anti-Anxiety Agents - pharmacology; Brain - enzymology; Brain - metabolism; Ethanol; gamma-Aminobutyric Acid - metabolism; Glutamate Decarboxylase - metabolism; In Vitro Techniques; Male; Plant Extracts - pharmacology; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Solvents; Water
• ISSN: 0008-4212
• DOI: 10.1139/Y07-083

In Canada, the use of botanical natural health products (NHPs) for anxiety disorders is on the rise, and a critical evaluation of their safety and efficacy is required. The purpose of this study was to determine whether commercially available botanicals directly affect the primary brain enzymes responsible for gamma-aminobutyric acid (GABA) metabolism. Anxiolytic plants may interact with either glutamic acid decarboxylase (GAD) or GABA transaminase (GABA-T) and ultimately influence brain GABA levels and neurotransmission. Two in vitro rat brain homogenate assays were developed to determine the inhibitory concentrations (IC50) of aqueous and ethanolic plant extracts. Approximately 70% of all extracts that were tested showed little or no inhibitory effect (IC50 values greater than 1 mg/mL) and are therefore unlikely to affect GABA metabolism as tested. The aqueous extract of Melissa officinalis (lemon balm) exhibited the greatest inhibition of GABA-T activity (IC50 = 0.35 mg/mL). Extracts from Centella asiatica (gotu kola) and Valeriana officinalis (valerian) stimulated GAD activity by over 40% at a dose of 1 mg/mL. On the other hand, both Matricaria recutita (German chamomile) and Humulus lupulus (hops) showed significant inhibition of GAD activity (0.11-0.65 mg/mL). Several of these species may therefore warrant further pharmacological investigation. The relation between enzyme activity and possible in vivo mode of action is discussed.